CA19-9/Sialyl Lewisa (GI Tumor Marker) Antibody, IgM, Clone: [121SLE], Mouse, Monoclonal

Produktübersicht

• Artikelname: CA19-9/Sialyl Lewisa (GI Tumor Marker) Antibody, IgM, Clone: [121SLE], Mouse, Monoclonal
• Artikelnummer: NBT-MSM1-25-P0
• Hersteller Artikelnummer: MSM1-25-P0
• Alternativnummer: NBT-MSM1-25-P0-20,NBT-MSM1-25-P0-100
• Hersteller: NeoBiotechnologies
• Wirt: Mouse
• Kategorie: Antikörper
• Applikation: IHC
• Spezies Reaktivität: Human
• Immunogen: Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
• Alternative Synonym: CA19.9, Ovarian tumor antigen, Pancreatic tumor antigen, Sialyl Lewis a

Produktbeschreibung

CA19-9, a carbohydrate epitope expressed on a high MW (400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group an

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [121SLE]
• Molekulargewicht: >400kDa
• Isotyp: IgM
• NCBI: Not Known
• Formulierung: 200ug/ml of Ab Purified from Bioreactor Concentrate. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA at 1.0mg/ml.
• Antibody Type: Monoclonal Antibody

Anwendungsbeschreibung

• Anwendungsbeschreibung: Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95C followed by cooling at RT for 20 minutes), Optimal dilution f